Gain Therapeutics GANX
NASDAQ GANX
$1.98 -0.09 (-4.35%)
As of: Aug 20, 2026 · 3:59 PM EDT

Gain Therapeutics (GANX) Revenue (2020 - 2023)

Gain Therapeutics (GANX) posted quarterly Revenue of $55180.0 for Q1 2023, up 22.61% year-over-year from $45006.0 in Q1 2022, and up 838.89% quarter-over-quarter from -$7468.0 in Q4 2022.

Gain Therapeutics (GANX) Revenue (2020 - 2023) Analysis & Trends

Gain Therapeutics' Revenue history runs 4 years deep, the most recent figure standing at $55180.0 for Q1 2023.

  • In Q1 2023, Revenue rose 22.61% year-over-year to $55180.0; the TTM figure through Dec 2023 stood at $55180.0 (down 58.4% YoY), while the FY2023 annual figure was $55180.0, down 58.4% from the prior year.
  • Revenue for Q1 2023 stood at $55180.0, up from -$7468.0 in the prior quarter.
  • The five-year high for Revenue was $95102.0 in Q2 2022, with the low at -$7468.0 in Q4 2022.
  • The 4-year median for Revenue is $10640.5 (2020), against an average of $28150.4.
  • The sharpest annual moves came in 2021 and 2022: Revenue surged 1097.99% in 2021, then slumped 161.51% in 2022.
  • Gain Therapeutics' Revenue stood at $9139.0 in 2020, then soared by 32.86% to $12142.0 in 2021, then plunged by 161.51% to -$7468.0 in 2022, then jumped by 838.89% to $55180.0 in 2023.
  • Business Quant data shows GANX's Revenue at $55180.0 in Q1 2023, -$7468.0 in Q4 2022, and $95102.0 in Q2 2022.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Vertex Pharmaceuticals 137.11 Bn 129.26 Bn 2.84 Bn 3.33 Bn
2 Regeneron Pharmaceuticals 84.98 Bn 76.99 Bn 3.93 Bn 4.29 Bn
3 Argenx Se 64.52 Bn 59.33 Bn 1.37 Bn 1.52 Bn
4 Moderna 53.23 Bn 48.09 Bn 52.00 Mn 145.00 Mn
5 BeOne Medicines 41.23 Bn 36.14 Bn 1.53 Bn 1.71 Bn
6 Alnylam Pharmaceuticals 30.65 Bn 27.34 Bn 992.69 Mn 1.29 Bn
7 Insmed 27.15 Bn 25.99 Bn 358.27 Mn 425.49 Mn
8 Royalty Pharma 26.98 Bn 26.14 Bn - 674.14 Mn
9 BioNTech SE 26.78 Bn 8.39 Bn 668.28 Mn 1.06 Bn
10 Gain Therapeutics 85.12 Mn 85.12 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2023 55,180.00
Dec 31, 2022 -7,468.00
Jun 30, 2022 95,102.00
Mar 31, 2022 45,006.00
Dec 31, 2021 12,142.00
Sep 30, 2021 27,345.00
Jun 30, 2021 76,348.00
Mar 31, 2021 5,269.00
Dec 31, 2020 9,139.00
Sep 30, 2020 6,696.00
Jun 30, 2020 6,373.00
Mar 31, 2020 6,673.00